Baillie Gifford & Co. Sells 516,983 Shares of Cardlytics, Inc. (NASDAQ:CDLX)

Baillie Gifford & Co. lessened its holdings in Cardlytics, Inc. (NASDAQ:CDLX) by 91.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 50,413 shares of the company’s stock after selling 516,983 shares during the period. Baillie Gifford & Co. owned about 0.10% of Cardlytics worth $187,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CDLX. RBF Capital LLC lifted its stake in shares of Cardlytics by 311.9% in the 3rd quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after purchasing an additional 369,620 shares during the period. GSA Capital Partners LLP lifted its stake in shares of Cardlytics by 1,273.2% in the 3rd quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after purchasing an additional 354,474 shares during the period. Jacobs Levy Equity Management Inc. lifted its stake in shares of Cardlytics by 56.0% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 317,644 shares of the company’s stock worth $1,016,000 after purchasing an additional 113,966 shares during the period. Geode Capital Management LLC increased its holdings in Cardlytics by 7.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after acquiring an additional 73,484 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Cardlytics in the 3rd quarter worth approximately $153,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Trading Down 5.3 %

Shares of CDLX opened at $3.37 on Wednesday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics, Inc. has a 1 year low of $2.76 and a 1 year high of $20.52. The company has a 50 day simple moving average of $3.47 and a two-hundred day simple moving average of $3.73. The firm has a market cap of $171.26 million, a P/E ratio of -0.55 and a beta of 1.54.

Analyst Upgrades and Downgrades

CDLX has been the subject of several analyst reports. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $6.92.

Insider Buying and Selling at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 15,160 shares of the stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the completion of the sale, the chief executive officer now directly owns 215,494 shares of the company’s stock, valued at $844,736.48. This trade represents a 6.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Alexis Desieno sold 8,854 shares of the stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the sale, the chief financial officer now directly owns 121,976 shares of the company’s stock, valued at approximately $447,651.92. This trade represents a 6.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 64,597 shares of company stock valued at $232,550 in the last three months. 4.40% of the stock is currently owned by corporate insiders.

Cardlytics Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.